Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celcuity Inc.CELC · Entity 3991 | Director | June 05, 2026 | June 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celcuity Inc.
Report date June 05, 2026 · Filed June 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,745 |
Reported balance
After 2026-06-05 transaction · row 1
1 source rowRow 1 · 2026-06-05 · Grant · Acquired 1,530 · Balance 1,745 F1: Represents restricted stock units that will vest upon the earlier of (i) the 2027 annual meeting of stockholders of Celcuity Inc. or (ii) April 30, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that will vest upon the earlier of (i) the 2027 annual meeting of stockholders of Celcuity Inc. or (ii) April 30, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Seagen Inc.
Report date December 14, 2023 · Filed December 15, 2023
Section 16 reporting ended · disclosed 2023-12-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-12-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-12-14 · Disposition to issuer · Disposed 1,747 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding performance-based restricted stock unit granted in August 2023 (each, a "Company August 2023 PSU") that was unvested as of immediately prior to the Effective Time, was cancelled and converted into the right to receive a Parent cash-based award with respect to an amount in cash equal to the product of (i) the Merger Consideration, multiplied by (ii) the number of shares of Common Stock then subject to such Company August 2023 PSU, based on target performance. F1: Reflects the disposition of shares of common stock, par value $0.001 per share ("Common Stock"), of Seagen Inc. ("Issuer"), or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of March 12, 2023 (the "Merger Agreement"), by and among the Issuer, Pfizer Inc. ("Parent") and Aris Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of Parent, pursuant to which, at 12:01 a.m. EST on December 14, 2023, the effective time of the Merger (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a subsidiary of Parent (the "Merger"). |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the disposition of shares of common stock, par value $0.001 per share ("Common Stock"), of Seagen Inc. ("Issuer"), or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of March 12, 2023 (the "Merger Agreement"), by and among the Issuer, Pfizer Inc. ("Parent") and Aris Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of Parent, pursuant to which, at 12:01 a.m. EST on December 14, 2023, the effective time of the Merger (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a subsidiary of Parent (the "Merger").
F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding performance-based restricted stock unit granted in August 2023 (each, a "Company August 2023 PSU") that was unvested as of immediately prior to the Effective Time, was cancelled and converted into the right to receive a Parent cash-based award with respect to an amount in cash equal to the product of (i) the Merger Consideration, multiplied by (ii) the number of shares of Common Stock then subject to such Company August 2023 PSU, based on target performance.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 16, 2022 Filed Aug 17, 2022 21:16 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 988 | $170.22 | $168,172.52 |
DisclosureSEC source: 0001203311-22-000054 · edgardoc.xml · nonDerivative · entry 3 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,737 F4 · kind: Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F3 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 21:16 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 777 | $170.22 | $132,257.13 |
DisclosureSEC source: 0001203311-22-000054 · edgardoc.xml · nonDerivative · entry 2 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,725 F4 · kind: Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F3 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:16 UTC | Seagen Inc. SGEN · Entity 13956 | GrantCommon Stock | 13,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001203311-22-000054 · edgardoc.xml · nonDerivative · entry 1 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,502 F1 · security: These shares represent restricted stock units and will be settled in common stock upon vesting. F2 · date: Shares shall vest at a rate of 25% on each anniversary of August 15, 2022 until all shares are fully vested at the end of four years. F3 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 18:50 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 712 | $179.46 | $127,775.52 |
DisclosureSEC source: 0001203311-22-000045 · edgardoc.xml · nonDerivative · entry 1 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,771 F1 · kind: Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F2 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| May 16, 2022 Filed May 18, 2022 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 333 | $134.21 | $44,690.83 |
DisclosureSEC source: 0001203311-22-000037 · edgardoc.xml · nonDerivative · entry 1 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,483 F1 · kind: Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F2 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| April 20, 2022 Filed Apr 22, 2022 20:30 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 319 | $144.32 | $46,037.63 |
DisclosureSEC source: 0001203311-22-000030 · edgardoc.xml · nonDerivative · entry 1 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,816 F1 · kind: Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F2 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 162 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on January 31, 2022. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 17:34 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 1,129 | $149.85 | $169,180.65 |
DisclosureSEC source: 0001203311-21-000102 · edgardoc.xml · nonDerivative · entry 2 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,973 F1 · kind: Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F2 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 17:34 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 194 | $149.85 | $29,070.90 |
DisclosureSEC source: 0001203311-21-000102 · edgardoc.xml · nonDerivative · entry 1 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,102 F1 · kind: Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F2 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| September 23, 2021 Filed Sep 27, 2021 20:10 UTC | Seagen Inc. SGEN · Entity 13956 | GrantCommon Stock | 112 | $166.22 | $18,616.64 |
DisclosureSEC source: 0001203311-21-000077 · edgardoc.xml · nonDerivative · entry 1 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,296 F1 · security: These shares represent restricted stock units and will be settled in common stock upon vesting. F2 · date: The performance criteria for these restricted stock units were met. These restricted stock units will become fully vested on 09/20/23, subject to continuous service with the Company until the vesting date. F3 · balance_after: Number of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 19:49 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 555 | $167.52 | $92,971.10 |
DisclosureSEC source: 0000899243-21-034974 · doc4.xml · nonDerivative · entry 2 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,184 F1 · kind: Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F2 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 19:49 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 578 | $167.52 | $96,823.96 |
DisclosureSEC source: 0000899243-21-034974 · doc4.xml · nonDerivative · entry 1 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,739 F1 · kind: Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F2 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:29 UTC | Seagen Inc. SGEN · Entity 13956 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 23,526 | $0.00 Strike: $155.87 | $0.00 |
DisclosureSEC source: 0001203311-21-000065 · edgardoc.xml · derivative · entry 4 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,526 Underlying: Common Stock · 23,526 shares Expires 2031-08-16 F5 · derivative.exercise_date: Options shall vest at a rate of 25% one year from grant date and monthly thereafter until all options are fully vested four years from grant date. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:29 UTC | Seagen Inc. SGEN · Entity 13956 | GrantIncentive Stock Option (right to buy) · Derivative | 642 | $0.00 Strike: $155.87 | $0.00 |
DisclosureSEC source: 0001203311-21-000065 · edgardoc.xml · derivative · entry 3 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 642 Underlying: Common Stock · 642 shares Expires 2031-08-16 F5 · derivative.exercise_date: Options shall vest at a rate of 25% one year from grant date and monthly thereafter until all options are fully vested four years from grant date. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:29 UTC | Seagen Inc. SGEN · Entity 13956 | GrantCommon Stock | 9,907 | $0.00 | $0.00 |
DisclosureSEC source: 0001203311-21-000065 · edgardoc.xml · nonDerivative · entry 2 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,317 F3 · security: These shares represent restricted stock units and will be settled in common stock upon vesting. F4 · date: Shares shall vest at a rate of 25% on each anniversary of August 15, 2021 until all shares are fully vested at the end of four years. F2 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:29 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 777 | $154.55 | $120,088.46 |
DisclosureSEC source: 0001203311-21-000065 · edgardoc.xml · nonDerivative · entry 1 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,410 F1 · kind: Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F2 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| July 02, 2021 Filed Jul 6, 2021 20:13 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 703 | $158.41 | $111,362.23 |
DisclosureSEC source: 0000899243-21-027689 · doc4.xml · nonDerivative · entry 1 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,187 F1 · kind: Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F2 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| May 17, 2021 Filed May 19, 2021 19:10 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 334 | $145.95 | $48,746.33 |
DisclosureSEC source: 0001203311-21-000038 · edgardoc.xml · nonDerivative · entry 1 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,890 F1 · kind: Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F2 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 147 shares acquired under the Amended & Restated 2000 Employee Stock Purchase Plan on January 29, 2021. Read SEC document |
| December 03, 2020 Filed Dec 3, 2020 17:45 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,666 | $0.00 Strike: $39.15 | $0.00 |
DisclosureSEC source: 0001203311-20-000134 · edgardoc.xml · derivative · entry 6 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,666 shares Expires 2025-08-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options vested at a rate of 25% on 8/25/2016 and monthly thereafter until all options were fully vested on 8/25/19. Read SEC document |
| December 03, 2020 Filed Dec 3, 2020 17:45 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 7,666 | $179.30 | $1,374,513.80 |
DisclosureSEC source: 0001203311-20-000134 · edgardoc.xml · nonDerivative · entry 4 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,077 F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| December 03, 2020 Filed Dec 3, 2020 17:45 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionCommon Stock | 7,666 | $39.15 | $300,123.90 |
DisclosureSEC source: 0001203311-20-000134 · edgardoc.xml · nonDerivative · entry 3 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 17:45 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $39.15 | $0.00 |
DisclosureSEC source: 0001203311-20-000134 · edgardoc.xml · derivative · entry 5 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,666 Underlying: Common Stock · 6,000 shares Expires 2025-08-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options vested at a rate of 25% on 8/25/2016 and monthly thereafter until all options were fully vested on 8/25/19. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 17:45 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 6,000 | $179.09 | $1,074,539.40 |
DisclosureSEC source: 0001203311-20-000134 · edgardoc.xml · nonDerivative · entry 2 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,077 F2 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $179.07 to $179.22. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 17:45 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionCommon Stock | 6,000 | $39.15 | $234,900.00 |
DisclosureSEC source: 0001203311-20-000134 · edgardoc.xml · nonDerivative · entry 1 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,151 | $0.00 Strike: $44.09 | $0.00 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · derivative · entry 21 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,151 shares Expires 2024-08-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Options vested at a rate of 25% on the anniversary of the vesting commencement and monthly thereafter until all options were fully vested on 8/26/18. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,590 | $0.00 Strike: $34.20 | $0.00 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · derivative · entry 20 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,179 Underlying: Common Stock · 1,590 shares Expires 2026-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Options vested at a rate of 25% on each anniversary of the vesting commencement date of March 20, 2018 until all options are fully vested four years from the vesting commencement date. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 2,207 | $0.00 Strike: $45.30 | $0.00 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · derivative · entry 19 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,207 shares Expires 2026-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Options vested at a rate of 25% on the anniversary of the vesting commencement and monthly thereafter until all options were fully vested on 8/27/20. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 1,276 | $0.00 Strike: $44.09 | $0.00 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · derivative · entry 18 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,276 shares Expires 2024-08-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Options vested at a rate of 25% on the anniversary of the vesting commencement and monthly thereafter until all options were fully vested on 8/26/18. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 1,218 | $0.00 Strike: $41.04 | $0.00 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · derivative · entry 17 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,218 shares Expires 2023-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Options vested at a rate of 25% on the anniversary of the vesting commencement and monthly thereafter until all options were fully vested on 8/19/17. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 2,220 | $0.00 Strike: $39.15 | $0.00 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · derivative · entry 16 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,220 shares Expires 2025-08-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Options vested at a rate of 25% on the anniversary of the vesting commencement and monthly thereafter until all options were fully vested on 8/25/19. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 417 | $0.00 Strike: $31.37 | $0.00 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · derivative · entry 15 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 417 shares Expires 2025-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Options vested at a rate of 25% on the anniversary of the vesting commencement and monthly thereafter until all options were fully vested on 2/3/19. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 1,218 | $178.63 | $217,571.34 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · nonDerivative · entry 14 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,077 F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionCommon Stock | 1,218 | $41.04 | $49,986.72 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · nonDerivative · entry 13 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 1,276 | $178.68 | $227,995.68 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · nonDerivative · entry 12 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,077 F4 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $178.63 to $178.69. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionCommon Stock | 1,276 | $44.09 | $56,258.84 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · nonDerivative · entry 11 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 5,151 | $178.63 | $920,123.13 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · nonDerivative · entry 10 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,077 F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionCommon Stock | 5,151 | $44.09 | $227,107.59 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · nonDerivative · entry 9 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 417 | $182.44 | $76,077.48 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · nonDerivative · entry 8 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,077 Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionCommon Stock | 417 | $31.37 | $13,081.29 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · nonDerivative · entry 7 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 2,220 | $182.45 | $405,039.00 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · nonDerivative · entry 6 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,077 F3 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $182.44 to $182.54. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionCommon Stock | 2,220 | $39.15 | $86,913.00 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · nonDerivative · entry 5 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 2,207 | $182.44 | $402,645.08 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · nonDerivative · entry 4 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,077 F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionCommon Stock | 2,207 | $45.30 | $99,977.10 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · nonDerivative · entry 3 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 1,590 | $182.37 | $289,968.30 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · nonDerivative · entry 2 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,077 F2 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $182.23 to $182.35. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 19:34 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionCommon Stock | 1,590 | $34.20 | $54,378.00 |
DisclosureSEC source: 0001203311-20-000126 · edgardoc.xml · nonDerivative · entry 1 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 20:23 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 1,620 | $0.00 Strike: $26.10 | $0.00 |
DisclosureSEC source: 0001203311-20-000118 · edgardoc.xml · derivative · entry 12 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,620 shares Expires 2022-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Options were fully vested on 8/20/16. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 20:23 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 799 | $0.00 Strike: $18.46 | $0.00 |
DisclosureSEC source: 0001203311-20-000118 · edgardoc.xml · derivative · entry 11 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 799 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Options were fully vested on 2/29/16. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 20:23 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 2,778 | $0.00 Strike: $15.46 | $0.00 |
DisclosureSEC source: 0001203311-20-000118 · edgardoc.xml · derivative · entry 10 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,778 shares Expires 2021-08-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options were fully vested on 8/24/15. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 20:23 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 864 | $169.51 | $146,456.64 |
DisclosureSEC source: 0001203311-20-000118 · edgardoc.xml · nonDerivative · entry 9 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,077 F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 20:23 UTC | Seagen Inc. SGEN · Entity 13956 | SaleCommon Stock | 2,778 | $172.50 | $479,205.00 |
DisclosureSEC source: 0001203311-20-000118 · edgardoc.xml · nonDerivative · entry 8 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,941 F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 20:23 UTC | Seagen Inc. SGEN · Entity 13956 | Exercise / conversionCommon Stock | 2,778 | $15.46 | $42,947.88 |
DisclosureSEC source: 0001203311-20-000118 · edgardoc.xml · nonDerivative · entry 7 ROMP CHARLES R · CIK 0001809717 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.